Targeted Nanoparticles Reprogram Immune Cells to Reverse Atherosclerosis
Novel liposome therapy delivers miR-10a to atherosclerotic plaques, reprogramming inflammatory macrophages and reducing disease progression in mice.
6113 articles
Novel liposome therapy delivers miR-10a to atherosclerotic plaques, reprogramming inflammatory macrophages and reducing disease progression in mice.
BCG therapy for bladder cancer travels to bone marrow, reprogramming stem cells to produce enhanced immune cells that fight tumors throughout the body.
New research reveals how lactate triggers lactylation, an epigenetic modification that fuels rheumatoid arthritis and lupus progression.
New review explores how epigenetic changes control the earliest stages of mammalian embryo development and cellular identity.
Even equally fit athletes and HCM patients show distinct breathing efficiency patterns during exercise testing.
New research questions whether maximal oxygen consumption truly reflects metabolic wellness in clinical practice.
New review examines how VO2 max testing is transforming cardiovascular care and identifies critical gaps in clinical application.
New insights into cardiopulmonary exercise testing protocols and their clinical applications for heart health evaluation.
New research reveals how declining estrogen and gut bacteria changes create a perfect storm for Alzheimer's disease in women.
Review reveals how gut microbiome imbalances drive major eye diseases like macular degeneration and diabetic retinopathy.
New study shows eating fiber-rich, microbiota-supporting foods improves cognitive function through gut bacteria mediation.
Indole compounds from gut microbes reduce meth-induced depression and anxiety through brain receptor signaling.